SCHEMBL24449447

SCHEMBL24449447

CC(C)(C)CC1CCCN(C(=O)N2CCC2)C1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
LIPE Q05469 1/20 0.39
LMNA P02545 1/20 0.37
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
TP53 P04637 1/20 0.36
EPHX2 P34913 2/20 0.35
CYP2D6 P10635 1/20 0.35
KCNH2 Q12809 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
POLB P06746 2/20 0.34
MAPT P10636 2/20 0.34
THRA P10827 1/20 0.34
THRB P10828 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD11B1 P28845 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4403492 0.97 ALDH1A1 (0.45) ALDH1A1LIPELMNAMEN1KMT2A
SCHEMBL24449453 0.95 ALDH1A1 (0.45) ALDH1A1LIPELMNAMEN1KMT2A
SCHEMBL24448825 0.93 ALDH1A1 (0.45) ALDH1A1LIPELMNAMEN1KMT2A
SCHEMBL24448830 0.90 ALDH1A1 (0.49) ALDH1A1MEN1KMT2ATP53CYP2D6
SCHEMBL24448832 0.88 ALDH1A1 (0.47) ALDH1A1MEN1KMT2ACYP2D6KCNH2
SCHEMBL24449801 0.87 ALDH1A1 (0.45) ALDH1A1LMNAMEN1KMT2ATP53
SCHEMBL25961351 0.87 ALDH1A1 (0.38) ALDH1A1LIPELMNAMEN1KMT2A
SCHEMBL4402801 0.84 CYP4F2 (0.39) ALDH1A1LMNAEPHX2POLBNPC1
SCHEMBL24449560 0.83 ALDH1A1 (0.38) ALDH1A1LMNAMEN1KMT2AEPHX2
SCHEMBL24449661 0.80 METAP1 (0.44) ALDH1A1LMNAMEN1KMT2ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357208-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS Epizyme, Inc. (US) 2023-11-09 US disclosed
US-20230357208-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS Epizyme, Inc. (US) 2023-11-09 US disclosed
US-11685732-B2 MYST family histone acetyltransferase inhibitors Epizyme, Inc. (US) 2023-06-27 US disclosed
US-11685732-B2 MYST family histone acetyltransferase inhibitors Epizyme, Inc. (US) 2023-06-27 US disclosed
US-20220162197-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS Epizyme, Inc. 2022-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220162197-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS EP300, KAT2A, KAT6A ALDH1A1 2786/4885LIPE 1978/4885LMNA 2503/4885
US-20230357208-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS EP300, KAT2A, KAT6A ALDH1A1 2786/4885LIPE 1978/4885LMNA 2503/4885
US-11685732-B2 MYST family histone acetyltransferase inhibitors EP300, KAT2A, KAT6A ALDH1A1 2786/4885LIPE 1978/4885LMNA 2503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.